HDL Therapeutics Secures $2,045,000 Series B Funding
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=d76583e9-1bac-4df9-8b73-efb4f3663874 - Date
12/31/2014 - Company Name
HDL Therapeutics - Mailing Address
46701 Commerce Center Drive Plymouth, MI 48170 USA - Company Description
The company is developing various biotechnologies. - Website
Undisclosed
- Transaction Type
Venture Equity - Transaction Amount
$2,045,000 - Transaction Round
Series B - Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities. - M&A Terms
- Venture Investor
